Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jupiter Neurosciences (JUNS) Revenue (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Revenue for 2 consecutive years, with -$62463.0 as the latest value for Q4 2025.

  • Quarterly Revenue fell 421.06% to -$62463.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$66020.0 through Dec 2025, up 61.16% year-over-year, with the annual reading at $21796.0 for FY2025, N/A changed from the prior year.
  • Revenue for Q4 2025 was -$62463.0 at Jupiter Neurosciences, down from -$1193.0 in the prior quarter.
  • The five-year high for Revenue was $19455.0 in Q4 2024, with the low at -$107382.0 in Q3 2024.